The biotech sector has underperformed the overall market. Those are sentiments echoed by JPMorgan analyst Chris Schott, given ...

China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and funds ...

Biotech stock Verve Therapeutics Inc (NASDAQ:VERV) is up 75.3% to trade at $10.99 at last check amid news that peer Eli Lilly ...

The FDA Commissioner Marty Makary stated the FDA will reach its 2025 drug approval targets despite severe workforce ...

How did Regencell Bioscience stock surge 64,000% with no revenue? Explore the role of its stock split & its tiny float.

The cancer diagnostics and treatment company priced above its previously planned range and might signal a renewed appetite ...

Verve Therapeutics stock jumped after a report said pharmaceutical giant Eli Lilly is in advanced talks to buy the ...

Recursion Pharmaceuticals (NASDAQ: RXRX) is not the most famous artificial intelligence (AI) stock on the market, but the ...

China's biotechnology stocks have experienced a significant rally, outperforming AI, with a 60% surge since January due to ...

The rally in the sector this year outpaces the 17% gain in China’s tech stocks that was driven by the release of DeepSeek’s ...